Biology News
Evolution AI Corporation Strengthens Offer to Purchase Pulse Evolution shares for $1.10 per Share; Announces Public ... - PR Newswire (press release)


PR Newswire (press release)
HOBE SOUND, Fla., May 24, 2018 /PRNewswire/ -- Evolution AI Corporation today reiterated its offer to purchase unrestricted, 'public float' shares in Pulse Evolution Corporation (OTC:PLFX), at $1.10 per share, in registered and freely marketable share ...

Using Medicine and Science to Improve the Quality of Life - New York Times


New York Times
Professor, department of Stem Cell Biology and Medicine, faculty of medical sciences at Kyushu University, Fukuoka, Japan. Katsuhiko Hayashi smiles when he thinks about helping to restore the white rhinoceros. The last male of the species died in March ...

Want to knock out the whole biology series this summer? - Dailyuw


Dailyuw
For many STEM majors, the introductory biology series is one of the first major challenges in working toward their degree. The three-quarter series throughout most students' sophomore year can be grueling, but not as grueling as the department of ...

International Stem Cell Corporation

Carlsbad, California - United States

International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called 'parthenogenesis' that promises to significantly advance the field of regenerative medicine by addressing the significant problem of immune-rejection. Parthenogenesis utilizes unfertilized human eggs to create 'parthenogenetic' stem cells (hpSC) that can be 'immune-matched' to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the world's population. ISCO plans to create a bank of these valuable hpSC lines (UniStemCell) to serve all populations across the world.

Human parthenogenetic stem cells have great therapeutic potential, yet do not require viable human embryos, thus avoiding ethical issues. ISCO's scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.

Related
International Stem Cell Corporation
United States

ISCO has developed breakthrough human stem cell lines that promise to eliminate the rejection of transplanted cells by the patient's immune system.

International Society for Stem Cell Research
United States

Promotes exchange and dissemination of information and ideas. Includes glossary, FAQ, scientific resources, human embryonic stem cell line publications, news archives, job and CV listings, and membership contacts in Northbrook, Illinois.

The Stem Cell Debate
United States

Includes resources from TIME magazine, as well as web-only analysis and commentary.

Stem Cell Directory
United States

Stem Cell Directory is a Fully Searchable, Human-edited Directory for the entire Stem Cell Industry

Stem Cell Patents
United States

Index of intellectual property, with news, journal articles, video interviews, and job opportunities in the USA.

UK Stem Cell Bank
United Kingdom

National repository for lines of embryonic and tissue origin. Includes FAQ, instructions for deposition and requesting batches, with contacts in London.

Stem Cell Information
United States

Official resource about research, using human embryonic lines under Federal policy, eligibility criteria, funding opportunities for scientists. Includes FAQ maintained by the National Institutes of Health, Maryland.

Stem Cell Resources
United States

Hundreds of peer-reviewed, scientifically credible resources providing stem cell information and education for students, teachers and the general public.

Stem Cell Technologies
United States

Provides a variety of in vivo and in vitro assays to evaluate small-molecule compound effects on stem cell systems, including toxicity effects in blood or bone marrow, hematopoietic modulation as well as assessment of hematological parameters and progenitor content in clinical samples.

The Stem Cell Source
United States

The Cord Blood Registry provides a blog about the science and usage of newborn stem cells.